| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.07 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.07 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.07 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.098 | 0.08 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.064 | 0.08 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.064 | 0.08 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.062 | 0.08 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.08 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.08 |